Literature DB >> 11069786

Geographic distribution of human immunodeficiency virus-associated Pneumocystis carinii pneumonia in San Francisco.

A M Morris1, M Swanson, H Ha, L Huang.   

Abstract

The epidemiology of Pneumocystis carinii pneumonia (PCP) and its geographic distribution are incompletely understood. We examined the influence of geographic location as a risk factor for PCP through a retrospective case-control study of HIV-infected persons evaluated for PCP at San Francisco General Hospital. Subjects had microscopically confirmed PCP diagnosed between January 1996 and June 1999. Control subjects had a presentation suggestive of PCP, but had bronchoalveolar lavage examination that did not reveal P. carinii. Medical chart review was performed to obtain demographic and clinical characteristics of the subjects as well as their addresses at time of PCP evaluation. Multivariate analyses were performed in order to identify variables associated with PCP. Lack of P. carinii prophylaxis and a CD4 cell count </= 50 cells/microl were independent predictors of an increased risk of PCP. Interestingly, subjects living in the 94103 zip code had a significantly lower risk of PCP than subjects in other areas (odds ratio = 0.2, 95% confidence interval 0.1-0.6, p < 0.01). This effect was present despite controlling for risk factors for PCP such as use of prophylaxis or antiretroviral therapy, CD4 cell count, and HIV RNA level. We conclude that residence in the 94103 zip code of San Francisco is associated with a substantially lower risk of PCP than residence in other areas of the city.

Entities:  

Mesh:

Year:  2000        PMID: 11069786     DOI: 10.1164/ajrccm.162.5.2002065

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  Analysis of a population-based Pneumocystis carinii pneumonia index as an outcome measure of access and quality of care for the treatment of HIV disease.

Authors:  Peter S Arno; Marc N Gourevitch; Ernest Drucker; Jing Fang; Clara Goldberg; Margaret Memmott; Karen Bonuck; Nandini Deb; Ellie Schoenbaum
Journal:  Am J Public Health       Date:  2002-03       Impact factor: 9.308

2.  Genotypes of Pneumocystis jiroveci isolates obtained in Harare, Zimbabwe, and London, United Kingdom.

Authors:  Robert F Miller; Austin R Lindley; Helen E Ambrose; Adam S Malin; Ann E Wakefield
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

3.  Pneumocystis carinii f. sp. hominis DNA in immunocompetent health care workers in contact with patients with P. carinii pneumonia.

Authors:  R F Miller; H E Ambrose; A E Wakefield
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

Review 4.  The ecology of pneumocystis: perspectives, personal recollections, and future research opportunities.

Authors:  Peter D Walzer
Journal:  J Eukaryot Microbiol       Date:  2013-09-03       Impact factor: 3.346

Review 5.  Colonization by Pneumocystis jirovecii and its role in disease.

Authors:  Alison Morris; Karen A Norris
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

6.  Genotypic variation in Pneumocystis jirovecii isolates in Britain.

Authors:  R F Miller; A R Lindley; A Copas; H E Ambrose; R J O Davies; A E Wakefield
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

7.  Environmental risk factors for Pneumocystis pneumonia hospitalizations in HIV patients.

Authors:  Kpandja Djawe; Linda Levin; Alexandra Swartzman; Serena Fong; Brenna Roth; Anuradha Subramanian; Katherine Grieco; Leah Jarlsberg; Robert F Miller; Laurence Huang; Peter D Walzer
Journal:  Clin Infect Dis       Date:  2012-10-05       Impact factor: 9.079

Review 8.  A Molecular Window into the Biology and Epidemiology of Pneumocystis spp.

Authors:  Liang Ma; Ousmane H Cissé; Joseph A Kovacs
Journal:  Clin Microbiol Rev       Date:  2018-06-13       Impact factor: 26.132

9.  Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages.

Authors:  Suk-Joong Yong; Zvezdana Vuk-Pavlovic; Joseph E Standing; Erika C Crouch; Andrew H Limper
Journal:  Infect Immun       Date:  2003-04       Impact factor: 3.441

Review 10.  Pneumocystis jirovecii infection: an emerging threat to patients with rheumatoid arthritis.

Authors:  Shunsuke Mori; Mineharu Sugimoto
Journal:  Rheumatology (Oxford)       Date:  2012-09-22       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.